Skip to content

Comparison of Efficacy of ESWL and Laser Lithotripsy in Chronic Pancreatitis With ERCP

ESWL Combined With ERCP and Laser Lithotripsy Combined With ERCP In Treatment of Pancreatic Duct Stones With Chronic Pancreatitis: a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05326542
Enrollment
80
Registered
2022-04-13
Start date
2022-09-30
Completion date
2022-12-31
Last updated
2022-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Duct Stone, Pancreatitis, Chronic

Keywords

Cholangiopancreatography, Endoscopic Retrograde, Lithotripsy

Brief summary

This study will compare the efficacy of ESWL and Laser Lithotripsy in the treatment of pancreatic duct stones with ERCP.

Detailed description

Chronic pancreatitis (CP) is an inflammatory disease that can causes progressive fibrosis of pancreatic tissue and eventually leads to damage of pancreatic exocrine and endocrine. According to statistics, the prevalence of CP in China is 13/10 million, which is still increasing. Pancreatic duct stones are the most important pathological changes of CP. More than 50% of patients with CP are accompanied by pancreatic duct stones, which can lead to pancreatic duct obstruction, hypertension and tissue ischemia. Removal of pancreatic duct stones under Endoscopic Retrograde Cholangiopancreatography (ERCP) are the first choice. ERCP is effective in the treatment of pancreatic duct stones by using basket and/or balloon catheter. But in most cases, ERCP is only suitable for the treatment of pancreatic duct stones (diameter \< 5mm) located in the head/body of the Pancreatic Duct (PD). PD stones larger than 5mm generally require Extracorporeal Shock Wave Lithotripsy (ESWL) or Endoscopic Intraductal Lithotripsy (EIL) for pretreatment. EIL includes Electrohydraulic Lithotripsy (EHL) and Laser Lithotripsy (LL). ESWL first locates the stone by X-ray, and then uses an electromagnetic pulse generator to direct a higher-energy shock wave to the stone, so that the stone is crushed by thousands of shock waves. The principle of laser lithotripsy is to make the stone absorb strong infrared rays and generate shock waves to achieve the purpose of fragmenting the stone. In view of the fact that there is no relevant research comparing the overall efficacy of ESWL combined with ERCP and EIL combined with ERCP, it is necessary to evaluate the differences in the therapeutic effects and complications of the two for PD stones. This research helps to provide evidence-based medical evidence, guide physicians' clinical practice, improve the quality of patients' lives, and reduce the economic burden of patients.

Interventions

PROCEDUREESWL and ERCP

First, ESWL will be used for lithotripsy, and then ERCP will be performed to clear the stones after lithotripsy.

PROCEDURELL and ERCP

After establishing the working channel under ERCP, the stone will be crushed with a laser lithotripter, and then ERCP will clear the stones after lithotripsy.

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* symptomatic adult patients diagnosed with chronic pancreatitis and pancreatic duct stones; * at least one stone (\>5 mm in diameter) located in the pancreatic duct of the head/body of the pancreas; * dilation of the proximal pancreatic duct.

Exclusion criteria

* history of ERCP or ESWL treatment; * suspected to have malignant tumors; * history of pancreatic surgery or gastrojejunostomy (Billroth II); * pancreatic pseudocyst with a diameter \>4cm; * bile duct stricture secondary to cholangitis or chronic pancreatitis; * acute pancreatitis exacerbation or acute exacerbation of chronic pancreatitis (including biliary pancreatitis); * coagulation dysfunction (INR≥1.5 or platelet count≤50×10\^9/L); * pregnant or breastfeeding women; * patients who refused to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
technical success ratesduring ERCP procedureTechnical success rates refer to the successful completion of standard procedures or the occurrence of complete spontaneous stone removal.
clearance rates of pancreatic duct stonesduring ERCP procedureClearance rates have been defined as complete, partial, or failure if the proportion of stones cleared was \> 90%, 50% - 90%, or \< 50%, respectively.

Secondary

MeasureTime frameDescription
time taken to completely clear the stoneduring ESWL and ERCP procedureThe time taken to completely clear the stones.
postoperative complications30 days after ERCP procedureMajor post-ERCP complications includes post-ERCP pancreatitis, bleeding, infection, and perforation, which are classified as mild, moderate, or severe, depending mainly on the length of hospitalization and the need for invasive treatment.
success rates of pancreatic duct decompressionduring ERCP procedureSuccessful removal of pancreatic duct obstruction factors by clearing stones and/or placing pancreatic duct stents/nasopancreatic catheters.

Other

MeasureTime frameDescription
abdominal pain relief rate30 days after ERCP procedurePostoperative and preoperative abdominal pain was assessed using the Visual Analogue Scale (VAS). VAS can be calculated ranging from 0 (no pain) to 100 (severe pain).

Countries

China

Contacts

Primary ContactLiang-hao Hu, MD
ianghao-hu@smmu.edu.cn+86-13817593520
Backup ContactZhao-shen Li, MD
zhaoshen-li@hotmail.com+86-13901960921

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026